Co-op, Biologic Therapeutics Discovery and Engineering
Biogen
Summary
This application is for a 6-month student role from January - June 2027. Resume review begins in October 2026.
Job description
We are seeking a co-op to join the Antibody Discovery group in Biodesign, a division of Therapeutic Modalities at Biogen. The individual will contribute to our mission to characterize antibody drug candidates from primary and optimization campaigns supporting therapeutic neurodegenerative disease programs. In this role, you will be joining a cross-functional team and performing experiments that will directly contribute to achieving drug discovery milestones.
What You’ll Do
The Antibody Discovery group is responsible for the discovery, characterization, and optimization of antibody therapeutics supporting research programs at Biogen. You will be involved in both discovery and optimization campaigns to nominate lead biologic drug candidates and perform in vitro experiments to biophysically characterize antibody drug candidates and validate clinical targets for cell-specific drug delivery for neurodegenerative and neuromuscular disease indications.
Who You Are
The ideal candidate will have some experience or familiarity with the following:
- Cell culture and sterile technique.
- Molecular cloning methods.
- Molecular biological techniques such as PCR, qRT-PCR, and DNA/RNA extraction.
- Plate-based protein binding assays such as ELISA and MSD.
- Experience with flow cytometry techniques and methods.
- (Preferred) Experience with executing python libraries, running scripts in a HPC environment, and / or training machine learning models with suitable python libraries such as PyTorch, scikit-learn, and TensorFlow. Experience with AI/ML de novo protein design using open source tools is a plus but not required.
- (Optional) Experience with biophysical protein binding characterization techniques such as SPR or BLI using Biacore or Octet instruments.
Education Requirements
- Pursuing a PhD or Master's degree.
- Majoring in: Computational Biology, Bioinformatics, Biochemistry, Immunology, Biological/Biomedical Engineering or a related field.
Requirements
- Legal authorization to work in the U.S.
- At least 18 years of age prior to the scheduled start date.
- Currently enrolled in an accredited community college, college, university or skills program/apprenticeship.
- Pursuing a PhD or Master's degree.
- Majoring in: Computational Biology, Bioinformatics, Biochemistry, Immunology, Biological/Biomedical Engineering or a related field.
- Cell culture and sterile technique.
- Molecular cloning methods.
- Molecular biological techniques such as PCR, qRT-PCR, and DNA/RNA extraction.
- Plate-based protein binding assays such as ELISA and MSD.
- Experience with flow cytometry techniques and methods.
- Preferred: Experience with executing python libraries, running scripts in a HPC environment, and / or training machine learning models with suitable python libraries such as PyTorch, scikit-learn, and TensorFlow.
- Optional: Experience with biophysical protein binding characterization techniques such as SPR or BLI using Biacore or Octet instruments.
Benefits
- Company paid holidays
- Commuter benefits
- Employee Resource Groups participation
- 80 hours sick time
Company overview
Founded in 1978, Biogen is a leading global biotechnology company headquartered in Cambridge, Massachusetts, specializing in the development and commercialization of innovative therapies for serious neurological and neurodegenerative diseases. As one of the oldest independent biotechnology companies in the United States, Biogen has established itself as a pioneer in neuroscience, focusing on difficult-to-treat conditions where few or no treatment options exist. The company's portfolio includes groundbreaking treatments for multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, ALS, and Friedreich's ataxia. With approximately 7,000 employees worldwide, Biogen operates through a global network that includes research and development hubs in Cambridge, Research Triangle Park in North Carolina, and South San Francisco, along with world-class manufacturing facilities in the United States and Switzerland. The company's commitment to scientific innovation is demonstrated by its Nobel Prize-winning founders and its receipt of the U.S. National Medal of Technology and Innovation. Biogen's patient-centric approach drives its mission to deliver transformative medicines that improve lives while creating sustainable value for shareholders and communities.